Searcharxiv⌕ Search

arXiv subjects

Paromita Roy

Publications and source records attributed to Paromita Roy.

2 recordsLinked to original sources

Can decision models extract clinical data from cancer pathology reports? An evaluation of accuracy, calibration, and failure modes

Decision models are a new class of language model that, instead of generating text, choose one option per question from a fixed list and return a probability for every option. They have not yet been evaluated on clinical text. We evaluated two open-weights decision models, Nimble 9B and Tev1 4B, for extracting 25 fields from 1,113 oral cavity cancer pathology reports from a single centre, against a prospectively maintained clinical database. We compared them with two generative models: Qwen3.5 9B, run locally, and GLM-5.3-flash, run through a cloud API. Tev1 reached a mean field accuracy of 0.917 (95% CI 0.913 to 0.920), the same as Qwen3.5 9B (0.918; p = 0.26), and was four times faster (15 s against 61 s per report). Nimble reached 0.862 and GLM-5.3-flash 0.986. Both decision models matched GLM-5.3-flash on simple dichotomous categories. They were weak on measurements binned into categories, on fields whose correct answer was not reported, and on some complex decisions (e.g. involved margins). We found that the main cause of the inferior performance of Nimble's came from asking 25 questions in one request: with two questions per request, its accuracy improved. Pooled over fields, the returned probabilities were well calibrated (expected calibration error 0.022 and 0.026), but they did not flag systematic errors within single fields. A simulated strategy of sending answers with a probability below 0.94 to GLM-5.3-flash raised Tev1's accuracy to 0.982, with 38% of answers escalated. Decision models can extract explicitly stated findings from pathology reports quickly on local hardware and return useful probabilities. They should be validated in the configuration in which they will be used, restricted to the fields in which they are reliable, and combined with other methods for numeric values.

cs.CL↗

Artificial Intelligence Assistance Significantly Improves Gleason Grading of Prostate Biopsies by Pathologists

While the Gleason score is the most important prognostic marker for prostate cancer patients, it suffers from significant observer variability. Artificial Intelligence (AI) systems, based on deep learning, have proven to achieve pathologist-level performance at Gleason grading. However, the performance of such systems can degrade in the presence of artifacts, foreign tissue, or other anomalies. Pathologists integrating their expertise with feedback from an AI system could result in a synergy that outperforms both the individual pathologist and the system. Despite the hype around AI assistance, existing literature on this topic within the pathology domain is limited. We investigated the value of AI assistance for grading prostate biopsies. A panel of fourteen observers graded 160 biopsies with and without AI assistance. Using AI, the agreement of the panel with an expert reference standard significantly increased (quadratically weighted Cohen's kappa, 0.799 vs 0.872; p=0.018). Our results show the added value of AI systems for Gleason grading, but more importantly, show the benefits of pathologist-AI synergy.

eess.IV↗